Inferior mesenteric vein thrombosis in the setting of testosterone therapy

BMJ Case Rep. 2022 Dec 14;15(12):e251886. doi: 10.1136/bcr-2022-251886.

Abstract

Inferior mesenteric vein thrombosis (IMVT) is a rare and potentially lethal complication that can progress to mesenteric ischaemia if left untreated. We report a case of a man in his 70s with a history of polycythaemia vera (PV) with a known negative Janus kinase-2 mutation (JAK2V617) who was started on testosterone therapy 2 months before presenting with left lower quadrant abdominal and flank pain. Evaluation revealed thrombocytosis and IMVT on CT scan. A non-operative approach was deferred for anticoagulation therapy. Within 24 hours, the patient demonstrated significant clinical improvement, and he subsequently made a full recovery. The patient underwent 6 months of anticoagulation therapy with Apixaban. This case documents the first case of IMVT in the setting of PV and testosterone therapy in the literature.

Keywords: Contraindications and precautions; Haematology (drugs and medicines); Medical education; Medical management.

Publication types

  • Case Reports

MeSH terms

  • Anticoagulants / therapeutic use
  • Humans
  • Male
  • Mesenteric Ischemia* / complications
  • Mesenteric Ischemia* / etiology
  • Mesenteric Veins / diagnostic imaging
  • Polycythemia Vera* / complications
  • Portal Vein
  • Testosterone / adverse effects
  • Venous Thrombosis* / complications
  • Venous Thrombosis* / diagnostic imaging
  • Venous Thrombosis* / drug therapy

Substances

  • Testosterone
  • Anticoagulants